查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1877453

奈米生物技术市场：依产品类型、治疗方法、应用、最终用户、国家及地区划分－全球产业分析、市场规模、市场占有率及2025-2032年预测

Nano-biotechnology Market, By Product Type, By Therapeutics, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年奈米生物技术市场规模价值为 1,712.3489 亿美元，从 2025 年到 2032 年以 9.5% 的复合年增长率成长。

奈米生物技术将奈米技术与生物技术结合，在分子和细胞层面开发用于医疗保健、农业和环境应用的材料和装置。标靶药物传递和诊断工具的进步加速了相关研究，目前全球已有超过350种奈米药物产品正在进行临床试验。然而，高昂的製造成本和监管障碍限制了其大规模商业化。对精准医疗、生物影像解决方案和永续农业实践日益增长的需求，为新创公司和成熟公司提供了创新机会。此外，大学与生技公司之间的合作，例如麻省理工学院与NanoTech公司的合作，正在拓展研发能力和产品线，增强了该领域的潜力，使其能够克服成本和政策方面的挑战。

奈米生物技术市场—市场动态

精准创新与新兴应用推动奈米生物技术市场发展

奈米生物技术透过将奈米技术与生物系统结合，创造出创新解决方案，正在彻底改变医疗保健、农业和环境领域。在医疗领域，美国国家奈米技术计画重点关注奈米医学的进步，包括标靶药物递送系统和诊断工具，这些工具能够提高治疗效果并促进疾病的早期检测。例如，美国食品药物管理局（FDA）已批准多种奈米技术疗法，例如用于癌症治疗的脂质体阿霉素製剂Doxil。在农业领域，奈米技术促进了智慧肥料和农药的开发，从而提高作物产量并减少对环境的影响。美国农业部一直支持奈米农业产品的研究，这些产品能够增强营养输送和提高作物的抗虫害能力。

奈米生物技术市场細項分析：

全球奈米生物技术市场按产品类型、治疗方法、应用、最终用户和地区进行细分。

依产品类型，奈米材料市场可分为五大类：奈米材料、奈米装置、奈米载体、试剂及耗材以及仪器及工具。奈米载体因其在标靶药物递送中的关键作用而占据市场主导地位，其次是用于诊断和治疗的奈米材料。奈米元件则位列第三，为精准应用提供支持，而仪器及工具和试剂及耗材在研发领域则占据中等重要性。

根据治疗领域，奈米生物技术市场分为五大类：癌症、牙科、心臟、骨科及其他。由于标靶药物传递和诊断的广泛研究，癌症治疗在奈米生物技术领域占据主导地位；其次是针对心血管疾病的心臟应用。骨科和牙科应用受到的关注度中等，而其他治疗领域，包括神经系统疾病和传染病，虽然正在兴起，但优先顺序较低。

奈米生物技术市场—地理洞察

奈米生物技术领域正经历显着的全球扩张，这主要得益于策略合作和收购。 2025年，奥尔巴尼大学奈米材料与奈米电子学先进技术中心（CATN2）获得了1000万美元的州政府拨款，用于推进半导体、微系统和生物医学技术的研究。这笔资金支持与包括GlobalFoundries和IBM在内的150多家公司的合作，预计将带来16亿美元的经济效益，并创造超过1,750个就业机会。此外，专注于脂质奈米颗粒技术的加拿大公司Precision NanoSystems被Cytiva收购，增强了其在mRNA疫苗开发方面的能力。这些发展凸显了该领域蓬勃发展的态势，而这种发展是由产学研合作和策略性企业整合所驱动的。

奈米生物技术市场—国家/地区洞察

美国在奈米生物技术领域仍维持全球领先地位，其策略性併购与合作是其显着特征。 2025年3月，阿斯特捷利康斥资高达10亿美元收购比利时生物技术公司EsoBiotec，旨在提升其细胞疗法能力，尤其是在癌症和自体免疫疾病领域。在此次收购之前，美国还进行了其他重大投资，包括以高达12亿美元收购Gracell Biotechnologies，以及在马里兰州投资3亿美元用于细胞疗法研发。此外，美国国家奈米技术计划持续资助跨学科研究，促进奈米医学和诊断领域的创新。这些进展凸显了该领域的蓬勃发展，而这种发展是由产学研合作和策略性企业整合所驱动的。

奈米生物技术市场—竞争格局：

奈米生物技术领域的竞争格局以策略性併购和合作为特征，这些措施旨在提升创新能力和市场地位。 2025年，阿斯特捷利康斥资高达10亿美元收购了EsoBiotec，以增强其细胞疗法能力，尤其是在癌症和自体免疫疾病领域。同样，赛诺菲宣布计划以11.5亿美元收购英国生技公司Vicebio，旨在增强其呼吸道疫苗产品线。在美国，奥尔巴尼大学奈米材料与奈米电子先进技术中心（CATN2）获得了1000万美元的州政府拨款，以加强其在半导体和微电子研究领域的作用，并促进与GlobalFoundries和IBM等公司的公私合作。这些发展凸显了奈米生物技术领域的蓬勃发展，而这种发展是由策略性的企业行动和机构支持共同驱动的。

目录

第一章：奈米生物技术市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
    • 奈米生物技术市场按产品类型分類的概览
    • 奈米生物技术市场概况（按治疗领域划分）
    • 奈米生物技术市场按应用领域分類的概览
    • 奈米生物技术市场按最终用户分類的概况
    • 各国奈米生物技术市场概况
    • 奈米生物技术市场概览（按地区划分）
  • 竞争洞察

第三章：奈米生物技术主要市场趋势

  • 奈米生物技术市场驱动因素
    • 市场驱动因素的影响分析
  • 奈米生物技术市场限制因素
    • 市场限制因素的影响分析
  • 奈米生物技术市场机会
  • 奈米生物技术市场未来趋势

第四章：奈米生物技术产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：奈米生物技术市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：奈米生物技术市场概况

  • 奈米生物技术市场份额分析，2024年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：奈米生物技术市场－依产品类型划分

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 奈米材料
      • 奈米管
      • 奈米颗粒
    • 奈米装置
      • 奈米晶片
      • 生物感测器
    • 奈米载体
      • 脂质体
      • 树状聚合物
    • 试剂和耗材
    • 仪器和工具

第八章：奈米生物技术市场－依治疗领域划分

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 癌症
    • 牙科
    • 心臟
    • 骨科
    • 其他的

第九章：奈米生物技术市场－按应用领域划分

  • 概述
    • 按应用领域分類的细分市场占有率分析
    • 药物递送
    • 诊断与影像
    • 再生医学
    • 组织工程
    • 疫苗研发

第十章：奈米生物技术市场－以最终用户划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药和生物技术公司
    • 研究机构
    • 医院和诊断实验室
    • 学术机构
    • 其他的

第十一章：奈米生物技术市场－依地域划分

  • 介绍
    • 按地域分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美奈米生物技术主要製造商
    • 北美市场规模及预测（按国家/地区划分）
    • 北美市场规模及预测（依产品类型划分）
    • 北美市场规模及预测（依治疗领域划分）
    • 北美市场规模及预测（按应用划分）
    • 北美市场规模及预测（依最终用户划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲奈米生物技术主要製造商
    • 欧洲市场规模及预测（按国家/地区划分）
    • 欧洲市场规模及预测（依产品类型划分）
    • 欧洲市场规模及预测（依治疗领域划分）
    • 欧洲市场规模及预测（按应用领域划分）
    • 欧洲市场规模及预测（依最终用户划分）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区奈米生物技术主要製造商
    • 亚太市场规模及预测（依国家/地区划分）
    • 亚太市场规模及预测（依产品类型划分）
    • 亚太地区市场规模及预测（依治疗领域划分）
    • 亚太市场规模及预测（按应用划分）
    • 亚太市场规模及预测（依最终用户划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲奈米生物技术主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区划分）
    • 拉丁美洲市场规模及预测（依产品类型划分）
    • 拉丁美洲市场规模及预测（依治疗领域划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（按最终用户划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲奈米生物技术主要製造商
    • MEA市场规模及预测（依国家/地区划分）
    • MEA市场规模及预测（依产品类型划分）
    • MEA市场规模及预测（依治疗领域划分）
    • MEA市场规模及预测（依应用划分）
    • MEA市场规模及预测（依最终用户划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 中东和非洲其他地区

第十二章：主要供应商分析－奈米生物技术产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Carl Zeiss AG
    • Danaher Corporation
    • GE Healthcare
    • Hitachi High-Technologies Corporation
    • Illumina, Inc.
    • JEOL Ltd.
    • Merck KGaA
    • Nanobiotix
    • Nikon Corporation
    • Oxford Instruments plc
    • PerkinElmer, Inc.
    • Qiagen NV
    • Shimadzu Corporation
    • Tecan Group Ltd.
    • Thermo Fisher Scientific, Inc.
    • Others

第十三章：360度AnalystView

第十四章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5708

Nano-biotechnology Market size was valued at US$ 171,234.89 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

Nano-biotechnology integrates nanotechnology with biotechnology to develop materials and devices at a molecular and cellular level for healthcare, agriculture, and environmental applications. Advancements in targeted drug delivery and diagnostic tools have accelerated research, with over 350 nanomedicine products currently in clinical trials globally. However, high manufacturing costs and regulatory hurdles limit large-scale commercialization. Growing demand for precision medicine, bio-imaging solutions, and sustainable agricultural practices presents opportunities for startups and established companies to innovate. Additionally, collaborations between universities and biotech firms, such as MIT partnering with NanoTech Inc., are expanding R&D capabilities and product pipelines, reinforcing the sector's potential despite cost and policy challenges.

Nano-biotechnology Market- Market Dynamics

Precision Innovations and Emerging Applications Propel Nano-biotechnology Market

Nano-biotechnology is revolutionizing healthcare, agriculture, and environmental sectors by merging nanotechnology with biological systems to create innovative solutions. In the medical field, the U.S. National Nanotechnology Initiative highlights advancements in nanomedicine, including targeted drug delivery systems and diagnostic tools that enhance treatment efficacy and early disease detection. For instance, the FDA has approved several nano-enabled therapeutics, such as Doxil, a liposomal formulation of doxorubicin used in cancer therapy. In agriculture, nanotechnology facilitates the development of smart fertilizers and pesticides, improving crop yield and reducing environmental impact. The U.S. Department of Agriculture has supported research into nano-based agricultural products that enhance nutrient delivery and pest resistance.

Nano-biotechnology Market- Segmentation Analysis:

The Global Nano-biotechnology Market is segmented on the basis of Product Type, Therapeutics, Application, End-User, and Region.

The market is divided into five categories based on product type: Nanomaterials, Nanodevices, Nanocarriers, Reagents & Consumables, and Instruments & Tools. Nanocarriers lead the market due to their critical role in targeted drug delivery, followed by nanomaterials for diagnostics and therapeutics. Nanodevices rank next, supporting precision applications, while instruments & tools and reagents & consumables hold moderate priority in research and development.

The market is divided into five categories based on Therapeutics: Cancer, Dental, Cardiac, Orthopedic, and Others. Cancer therapeutics dominate the nano-biotechnology segment owing to extensive research in targeted drug delivery and diagnostics, followed by cardiac applications addressing cardiovascular disorders. Orthopedic and dental applications hold a moderate focus, while other therapeutic areas, including neurological and infectious diseases, have emerging but lower priority.

Nano-biotechnology Market- Geographical Insights

The nano-biotechnology sector is experiencing significant global expansion, fueled by strategic collaborations and acquisitions. In 2025, the University at Albany's Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) secured a $10 million state grant to advance research in semiconductors, microsystems, and biomedical technologies. This funding supports partnerships with over 150 companies, including GlobalFoundries and IBM, contributing to an estimated economic impact of $1.6 billion and the creation of more than 1,750 jobs. Additionally, Precision NanoSystems, a Canadian firm specializing in lipid nanoparticle technologies, was acquired by Cytiva, enhancing capabilities in mRNA vaccine development. These developments underscore the sector's dynamic growth, driven by academic-industry partnerships and strategic corporate consolidations.

Nano-biotechnology Market- Country Insights

The United States remains a global leader in nano-biotechnology, marked by strategic mergers and collaborations. In March 2025, AstraZeneca acquired Belgian biotech firm EsoBiotec for up to $1 billion, aiming to enhance its cell therapy capabilities, particularly in cancer and autoimmune diseases. This acquisition follows other significant investments, including the purchase of Gracell Biotechnologies for up to $1.2 billion and a $300 million investment in Maryland for cell therapy development. Additionally, the U.S. National Nanotechnology Initiative continues to fund interdisciplinary research, fostering innovation in nanomedicine and diagnostics. These developments underscore the sector's dynamic growth, driven by academic-industry partnerships and strategic corporate consolidations.

Nano-biotechnology Market- Competitive Landscape:

The competitive landscape of nano-biotechnology is marked by strategic mergers, acquisitions, and collaborations that enhance innovation and market positioning. In 2025, AstraZeneca acquired EsoBiotec for up to $1 billion to advance its cell therapy capabilities, particularly in cancer and autoimmune diseases. Similarly, Sanofi announced plans to acquire UK-based biotech firm Vicebio for $1.15 billion, aiming to enhance its respiratory vaccine offerings. In the U.S., the University at Albany's Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) secured a $10 million state grant to bolster its role in semiconductor and microelectronics research, fostering public-private partnerships with companies like GlobalFoundries and IBM. These developments underscore the dynamic nature of the nano-biotechnology sector, driven by strategic corporate actions and institutional support.

Recent Developments:

In September 2024, scientists at the National Institute of Agricultural Botany (NIAB) developed a diagnostic kit to detect antibiotics in animal food, alongside a nano-mineral biocapsule for targeted delivery of nutrients, drugs, and bioactive molecules, enhancing food safety and precision nutrition.

In September 2024, NanoSyrinx secured £10 million (USD 12.2 million) funding to develop its innovative nano syringe delivery platform, enabling precise transport of peptide and protein payloads directly into the cytosol of targeted cells for advanced therapeutic applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANO-BIOTECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corporation
  • Illumina, Inc.
  • JEOL Ltd.
  • Merck KGaA
  • Nanobiotix
  • Nikon Corporation
  • Oxford Instruments plc
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Shimadzu Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Others

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanomaterials
  • Nanotubes
  • Nanoparticles
  • Nanodevices
  • Nanochips
  • Biosensors
  • Nanocarriers
  • Liposomes
  • Dendrimers
  • Reagents & Consumables
  • Instruments & Tools

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY THERAPEUTICS- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Dental
  • Cardiac
  • Orthopedic
  • Others

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • Diagnostics & Imaging
  • Regenerative Medicine
  • Tissue Engineering
  • Vaccine Development

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Hospitals & Diagnostic Labs
  • Academic Institutions
  • Others

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nano-biotechnology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nano-biotechnology Market Snippet by Product Type
    • 2.1.2. Nano-biotechnology Market Snippet by Therapeutics
    • 2.1.3. Nano-biotechnology Market Snippet by Application
    • 2.1.4. Nano-biotechnology Market Snippet by End-User
    • 2.1.5. Nano-biotechnology Market Snippet by Country
    • 2.1.6. Nano-biotechnology Market Snippet by Region
  • 2.2. Competitive Insights

3. Nano-biotechnology Key Market Trends

  • 3.1. Nano-biotechnology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nano-biotechnology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nano-biotechnology Market Opportunities
  • 3.4. Nano-biotechnology Market Future Trends

4. Nano-biotechnology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nano-biotechnology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nano-biotechnology Market Landscape

  • 6.1. Nano-biotechnology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nano-biotechnology Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Nanomaterials
      • 7.1.2.1. Nanotubes
      • 7.1.2.2. Nanoparticles
    • 7.1.3. Nanodevices
      • 7.1.3.1. Nanochips
      • 7.1.3.2. Biosensors
    • 7.1.4. Nanocarriers
      • 7.1.4.1. Liposomes
      • 7.1.4.2. Dendrimers
    • 7.1.5. Reagents & Consumables
    • 7.1.6. Instruments & Tools

8. Nano-biotechnology Market - By Therapeutics

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutics, 2024 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Dental
    • 8.1.4. Cardiac
    • 8.1.5. Orthopedic
    • 8.1.6. Others

9. Nano-biotechnology Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Delivery
    • 9.1.3. Diagnostics & Imaging
    • 9.1.4. Regenerative Medicine
    • 9.1.5. Tissue Engineering
    • 9.1.6. Vaccine Development

10. Nano-biotechnology Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biotechnology Companies
    • 10.1.3. Research Institutes
    • 10.1.4. Hospitals & Diagnostic Labs
    • 10.1.5. Academic Institutions
    • 10.1.6. Others

11. Nano-biotechnology Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Nano-biotechnology Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Nano-biotechnology Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Nano-biotechnology Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Nano-biotechnology Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Nano-biotechnology Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Nano-biotechnology Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Affymetrix, Inc.
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. Bruker Corporation
    • 12.2.6. Carl Zeiss AG
    • 12.2.7. Danaher Corporation
    • 12.2.8. GE Healthcare
    • 12.2.9. Hitachi High-Technologies Corporation
    • 12.2.10. Illumina, Inc.
    • 12.2.11. JEOL Ltd.
    • 12.2.12. Merck KGaA
    • 12.2.13. Nanobiotix
    • 12.2.14. Nikon Corporation
    • 12.2.15. Oxford Instruments plc
    • 12.2.16. PerkinElmer, Inc.
    • 12.2.17. Qiagen N.V.
    • 12.2.18. Shimadzu Corporation
    • 12.2.19. Tecan Group Ltd.
    • 12.2.20. Thermo Fisher Scientific, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us